李丽, 杨宝琦, 阮宏莹, 曹海光. 原发于鼻腔、鼻窦多形T细胞淋巴瘤临床分析[J]. 中国肿瘤临床, 2005, 32(13): 770-772.
引用本文: 李丽, 杨宝琦, 阮宏莹, 曹海光. 原发于鼻腔、鼻窦多形T细胞淋巴瘤临床分析[J]. 中国肿瘤临床, 2005, 32(13): 770-772.
Li Li, Yang Bao-qi, Ruan Hong-ying, . Clinical Analysis of Primay Polymorphic T-Cell Lymphoma in Nasal Cavity and Sinus[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(13): 770-772.
Citation: Li Li, Yang Bao-qi, Ruan Hong-ying, . Clinical Analysis of Primay Polymorphic T-Cell Lymphoma in Nasal Cavity and Sinus[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(13): 770-772.

原发于鼻腔、鼻窦多形T细胞淋巴瘤临床分析

Clinical Analysis of Primay Polymorphic T-Cell Lymphoma in Nasal Cavity and Sinus

  • 摘要: 目的: 探讨原发于鼻腔、鼻窦多形T细胞淋巴瘤(polymorphic T-cell lymphoma)的治疗方法。 方法: 回顾分析1997年1月~2003年1月间天津市第一中心医院耳鼻咽喉科诊治的14例原发于鼻腔、鼻窦多形T细胞淋巴瘤患者的临床资料。对所有的患者行全面的检查及临床分期,分别采用单纯放疗,化疗+放疗+化疗的治疗方法。 结果: 14例中ⅠE期2例采用单纯放疗完全缓解(CR)随访19、77个月无复发;ⅡE期8例其中3例采用化疗50天~2个月内死亡,5例采用化疗+放疗+化疗,完全缓解(CR),随访20、32、63、63、76个月无复发,ⅣE期4例,其中3例采用化疗分别于1~4个月内死亡,1例采用化疗+放疗+化疗,部分缓解(PR),随访64个月无复发。 结论: 原发于鼻腔和鼻窦的多形T细胞淋巴瘤,ⅠE期可采用单纯放疗,ⅡE期~ⅣE期应采用化疗+放疗+化疗的综合治疗。CHOP仍是首选的标准化疗方案。

     

    Abstract: Objective : To explore the method of treatment on polymorphic T-Cell lymphoma of nasal cavity and sinus. Methods : The data of 14 patients with polymorphic T-Cell lymphoma were reviewed and the results after treatment with simple radiotherapy or radiotherapy after chemotherapy, followed by chemotherapy were analyzed. Results : Of all the 14 cases, 2 cases were IE stage with completed relief (CR) after simple radiotherapy, and were followed-up from 19 to 77 months without relapse. Eight cases were Ⅱ E, of which 3 accepted chemotherapy, died in 50 days to 2 months. The other 5 cases achieved C R by radiotherapy after chemotherapy followed by chemotherapy, and were followed-up for 20,32,63,76 months respectively without recurrence. Four cases were ⅣE stsge, among which 3 died in 1 to 4 months after chemotherapy. The other one with partial remission (PR) was treated by radio therapy after chemotherapy, followed by chemotherapy, with no recurrence, and were followed-up for 64 months. Conclusion : To treat primary the polymorphic T-Cell lymphoma of nasal cavity and sinus, it is applicable to treat patients of IE stage with simple radiotherapy and Ⅱ E stage toⅣ E stage by systermatic chemotherapy after chemotherapy followed by radiotherapy.

     

/

返回文章
返回